ArticleFrontiers in immunology2025

Immune checkpoint inhibitors continuation beyond progression as second-line treatment for extensive-stage small-cell lung cancer: a real-world, multicenter analysis.

Jiao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.